Plain-English translation of NCT06849752 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →EAGLE-HF is an observational study that tracks people at risk for heart failure to understand how a blood test called NT-proBNP and ultrasound of the heart can help catch the condition earlier. The study also looks at whether factors like where you live and your doctor's specialty affect how heart failure is treated once diagnosed.
Heart failure is often caught too late, after symptoms become severe. This research aims to find the best ways to diagnose it early using simple blood tests, and to understand whether patients in less resourced communities or seeing different types of doctors receive consistent, guideline-recommended treatments.
You likely qualify if…
You likely don't qualify if…
You would visit Cleveland Clinic for a blood test (NT-proBNP) and a specialized heart ultrasound using artificial intelligence technology. Researchers would also ask you questions about your social circumstances, neighborhood, and medical history. If you develop heart failure within 6 months of enrollment, the study team would track what medications your doctor prescribes and compare treatment patterns across different types of doctors and neighborhoods. The study is observational, meaning you are not receiving a new medication—instead, researchers are carefully watching and documenting your care.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States